All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Dr. Shaila's ED claims about modern treatments checked

Dr. Shaila | India 🇮🇳

Instagram creator

9.9K viewsView on Instagram →

Quick answer

Erectile dysfunction affects roughly half of men over 40, with PDE5 inhibitors showing 70-80% efficacy rates in clinical trials. Testosterone replacement therapy only helps when ED is specifically caused by clinically low testosterone levels (below 300 ng/dL), which occurs in fewer than 30% of ED cases.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 3 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Dr. Shaila's ED claims about modern treatments checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Dr. Shaila's ED claims about modern treatments checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Dr. Shaila's ED claims about modern treatments checked" from Dr. Shaila | India 🇮🇳. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Erectile dysfunction affects roughly half of men over 40, with PDE5 inhibitors showing 70-80% efficacy rates in clinical trials.

The reason this review is not generic is the source wording and the canonical claim label "trt ed is more common than you think and more treatable than." In this clip, the useful excerpt is: ""ED is more common than you think — and more treatable than you know." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

PDE5 inhibitors like sildenafil work for 70-80% of men with ED in clinical trials
People who land here are usually comparing the Testosterone claim with MensHealth, MensFitness, and MensMentalHealth.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Erectile dysfunction affects roughly half of men over 40, with PDE5 inhibitors showing 70-80% efficacy rates in clinical trials.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Erectile dysfunction affects roughly half of men over 40, with PDE5 inhibitors showing 70-80% efficacy rates in clinical trials. Testosterone replacement therapy only helps when ED is specifically caused by clinically low testosterone levels (below 300 ng/dL), which occurs in fewer than 30% of ED cases.
  • 52% of men aged 40-70 experience some degree of erectile dysfunction according to the Massachusetts Male Aging Study
  • PDE5 inhibitors like sildenafil work for 70-80% of men with ED in clinical trials

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • 52% of men aged 40-70 experience some degree of erectile dysfunction according to the Massachusetts Male Aging Study
  • PDE5 inhibitors like sildenafil work for 70-80% of men with ED in clinical trials
  • Only 28% of men with ED have clinically low testosterone levels that would benefit from TRT
  • Testosterone replacement therapy carries FDA black box warnings about cardiovascular and other risks
  • Lifestyle changes including exercise and weight loss are recommended as first-line interventions alongside medications
  • Vascular issues and diabetes are more common causes of ED than low testosterone in most men
  • Proper evaluation should identify the underlying cause before starting any hormone therapy

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

Dr. Shaila's post makes three main claims: erectile dysfunction is more common than people realize, it's more treatable than people know, and modern medicine can restore "confidence, connection, and performance." She encourages men not to suffer in silence and to start with a conversation.

The post is categorized under testosterone replacement therapy (TRT), though she doesn't explicitly mention TRT in her caption. The hashtags target men over 40 and 50, suggesting an older demographic focus.

How common is erectile dysfunction really?

Dr. Shaila's right that ED is common, though the exact numbers vary by study and age group. The Massachusetts Male Aging Study found that 52% of men aged 40-70 experience some degree of ED, with prevalence increasing from 12% at age 40 to 46% at age 70.

More recent data from the Cleveland Clinic suggests even higher rates. A 2019 systematic review by Kessler et al. in Sexual Medicine found global ED prevalence ranging from 3% to 76.5%, depending on the population and severity criteria used.

The condition does increase dramatically with age. But calling it "more common than you think" depends entirely on what you already think.

Are modern ED treatments really that effective?

Here's where Dr. Shaila gets it mostly right. PDE5 inhibitors like sildenafil (Viagra) work for about 70-80% of men with ED, according to multiple clinical trials. The original Pfizer studies showed 69% efficacy for sildenafil versus 22% for placebo.

But her mention of TRT is more complicated. The 2018 TRAVERSE trial found that testosterone therapy improved erectile function scores by 2.9 points versus placebo in men with low testosterone and cardiovascular disease risk. That's statistically significant but clinically modest.

TRT works best when ED is actually caused by clinically low testosterone, which isn't always the case. Many men with normal testosterone levels won't see ED improvement from TRT.

What's the actual relationship between TRT and ED?

This is where things get murky, and Dr. Shaila's post doesn't help clarify. While low testosterone can contribute to ED, it's not the primary cause for most men. Vascular issues, diabetes, and psychological factors are more common culprits.

The American Urological Association's 2018 guidelines recommend checking testosterone levels in men with ED, but only treating with TRT if levels are actually low (typically below 300 ng/dL). Simply having ED doesn't mean you need testosterone.

A 2016 study by Corona et al. in the Journal of Sexual Medicine found that only 28% of men with ED had clinically low testosterone. For the other 72%, TRT wouldn't be the right first-line treatment.

What should men actually know about ED treatment?

Dr. Shaila's advice to "start with a conversation" is solid. But men should know that effective treatment depends on identifying the underlying cause, not just throwing testosterone at the problem.

For most men, PDE5 inhibitors remain first-line therapy because they're highly effective regardless of testosterone levels. The 2017 AUA guidelines recommend lifestyle changes (exercise, weight loss, smoking cessation) as equally important interventions.

TRT has real risks including increased red blood cell count, sleep apnea, and potential cardiovascular effects. The FDA requires black box warnings about these risks. Men shouldn't assume testosterone is a magic bullet for sexual performance issues without proper evaluation and monitoring.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Shaila | India 🇮🇳 · Instagram creator

9.9K views on this video

“ED is more common than you think — and more treatable than you know. Don’t suffer in silence. Modern medicine can help you restore confidence, connection, and performance. The first step is a convers

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 52% of men aged 40-70 experience some degree of erectile?

52% of men aged 40-70 experience some degree of erectile dysfunction according to the Massachusetts Male Aging Study

What does the video say about pde5 inhibitors like sildenafil work for 70-80% of men with?

PDE5 inhibitors like sildenafil work for 70-80% of men with ED in clinical trials

What does the video say about only 28% of men with ed have clinically low testosterone?

Only 28% of men with ED have clinically low testosterone levels that would benefit from TRT

What does the video say about testosterone replacement therapy carries fda black box warnings about cardiovascular?

Testosterone replacement therapy carries FDA black box warnings about cardiovascular and other risks

What does the video say about lifestyle changes including exercise?

Lifestyle changes including exercise and weight loss are recommended as first-line interventions alongside medications

What does the video say about vascular?

Vascular issues and diabetes are more common causes of ED than low testosterone in most men

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Shaila | India 🇮🇳, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.